Position in GSK
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$3,405,289,219
-$328,957,023 QoQ
Shares Held
64,961,641
-4.0% QoQ
Ownership
3.24%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#1
of 1,033 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 56%
Shared 0%
None 44%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FMR LLC holds $75,393,052,380 across 17 Drug Manufacturers - General names. GSK ranks #8 (4.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
28,462,475 | $34,138,749,234 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
66,870,816 | $8,448,458,890 | |
| 3 | MRK |
Merck & Co., Inc.
|
45,440,355 | $5,839,085,616 | |
| 4 | JNJ |
Johnson & Johnson
|
22,595,566 | $5,738,595,894 | |
| 5 | AZN |
Astrazeneca PLC
|
28,895,264 | $5,479,119,956 | |
| 6 | ABBV |
AbbVie Inc.
|
20,773,786 | $5,227,515,506 | |
| 7 | BIIB |
Biogen Inc.
|
18,217,239 | $3,936,016,655 | |
| 8 | GSK |
GSK plc
This page
|
64,961,641 | $3,405,289,219 |
All Filings in GSK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,405,289,219 | 64,961,641 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $3,734,246,242 | 67,661,646 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $3,308,699,814 | 67,469,409 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $2,854,753,458 | 66,143,500 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $2,342,536,089 | 61,003,544 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $2,329,068,827 | 60,120,517 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $1,786,474,940 | 52,823,032 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $1,185,884,974 | 29,008,928 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $1,031,206,444 | 26,784,583 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $1,053,796,984 | 24,581,222 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $717,708,812 | 19,366,131 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $656,107,344 | 18,099,513 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $599,049,662 | 16,808,352 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $550,651,449 | 15,476,432 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $525,711,300 | 14,960,481 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $414,009,319 | 14,067,595 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $751,490,834 | 17,601,698 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $722,689,216 | 16,915,438 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $767,643,250 | 17,747,631 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $647,213,576 | 17,269,912 | Shares | Defined | 2022-02-14 | |
| 2021-06-30 | $663,053,417 | 16,977,229 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $600,295,160 | 17,148,962 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $698,805,377 | 19,361,008 | Shares | Defined | 2021-02-08 | |
| 2020-09-30 | $729,604,182 | 19,763,199 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $798,720,956 | 19,964,614 | Shares | Defined | 2020-08-24 | |
| 2020-03-31 | $723,076,271 | 19,457,142 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||